Metabolism, Endocrinology & Diabetes (MEND)

Written By Kate Murphy

Overview

The Michigan Genomics Initiative - MEND (Metabolism, Endocrinology & Diabetes) is a specialized research effort dedicated to understanding the genetic factors influencing metabolic, endocrine, and diabetes-related conditions. The goal is to identify genetic variations that contribute to the development and progression of metabolic and endocrine disorders, including diabetes.  By doing so, MGI-MEND aims to advance personalized treatment strategies and preventive measures, ultimately improving patient outcomes.

Principal Investigator

Charles Burant, MD, PhD

Digital Health Innovation Support

Digital Health Innovation provided genetic data for this project.

Kate Murphy
Previous

ImPrec: Immune Precision in Solid Organ Transplantation (ImPrec)